Pfizer forecasts 24 percent COVID vaccination rate in US this year Ruchika Sharma19 Sept 2023 10:00 AM ISTNew York: Pfizer expects 24% of the U.S. population, or about 82 million people, to receive COVID-19 shots this year, CFO David Denton said at a...
Pfizer USD 43 billion bid for Seagen to be decided by EU antitrust regulators Ruchika Sharma16 Sept 2023 4:11 PM ISTBrussels: Pfizer's $43 billion bid for Seagen will be decided by EU antitrust regulators by Oct. 19, a regulatory filing showed on...
Pfizer, BioNTech gets USFDA nod for 2023-2024 COVID vaccine Ruchika Sharma12 Sept 2023 12:30 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental...
Generate Phase II Clinical Data on 20 Indian subjects for dose selection: CDSCO panel Tells Pfizer on Ritlecitinib Dr. Divya Colin10 Sept 2023 6:00 PM ISTNew Delhi: Noting that in the presented Phase II clinical trial data, no Indian subjects were involved and the study disease is very heterogeneous,...
Pfizer, Valneva report positive pediatric, adolescent phase 2 booster results for Lyme disease vaccine Ruchika Sharma10 Sept 2023 2:30 PM ISTNew York: Valneva SE and Pfizer Inc. have announced positive pediatric and adolescent immunogenicity and safety data for their Lyme...
Pfizer-BioNTech updated COVID vaccine approved by UK regulator Ruchika Sharma6 Sept 2023 10:00 AM ISTBengaluru: The UK drug regulator said on Tuesday it has approved an updated COVID-19 vaccine by Pfizer and its German partner BioNTech that targets...
Pfizer, BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID vaccine in EU Ruchika Sharma1 Sept 2023 2:46 PM ISTNew York: Pfizer Inc. and BioNTech SE have announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...
Pfizer expects to restart production at tornado hit plant by early Q4 Ruchika Sharma30 Aug 2023 10:00 AM ISTNorth Carolina: Pfizer said on Monday it expects to restart production at its North Carolina plant by the beginning of the fourth quarter of...
Pfizer gets European Commission marketing nod for RSV vaccine Abrysvo to protect infants, older adults Ruchika Sharma27 Aug 2023 11:00 AM ISTNew York: Pfizer Inc. has announced that the European Commission (EC) has granted marketing authorization for ABRYSVO, the company’s bivalent...
Pfizer gets USFDA priority review for prostate cancer drug Xtandi Ruchika Sharma26 Aug 2023 12:00 PM ISTXTANDI (enzalutamide) is an androgen receptor signaling inhibitor.
Pfizer maternal vaccine Abrysvo bags USFDA approval for RSV prevention in infants Ruchika Sharma22 Aug 2023 11:26 AM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO (Respiratory Syncytial Virus Vaccine),...
Pfizer Elrexfio bags USFDA accelerated nod for multiple myeloma treatment Ruchika Sharma16 Aug 2023 11:41 AM ISTNew York: Pfizer Inc. has announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval to ELREXFIO (elranatamab-bcmm) for...
